Tuesday, April 16, 2024 6:14:29 PM
No sellers in consecutive sessions.
Recent RANI News
- Rani Therapeutics to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:09:53 PM
- Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:04:34 PM
- Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:10:21 PM
- Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:06:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 01:05:09 PM
- Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist • GlobeNewswire Inc. • 12/14/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 10:18:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 01:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 01:00:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:10:09 PM
- Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third Qu • GlobeNewswire Inc. • 11/01/2023 08:05:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM